Company intelligence / Profile preview

Italmerck

Milan, Italy

Ownership: Private
Development stage: Other

Overview

Italmerck is an Italian pharmaceutical company focused on the development, production, and commercialization of a wide range of therapeutic products. The company operates primarily in the domestic Italian market, offering solutions across several therapeutic areas including gastroenterology, respiratory health, and pain management. Italmerck provides both branded and generic pharmaceutical products, maintaining a portfolio that addresses common clinical needs. Their business model emphasizes quality manufacturing and strategic distribution within the Italian healthcare system.

Therapeutic areas: NeurologyInfectious DiseasesPulmonologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Italmerck.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Italmerck.

Explore the full profile